免疫检查点蛋白与急性髓性白血病患者治疗结果之间的关联
Lukasz Bolkun1, Marlena Tynecka2, Alicja Walewska2
1Department of Haematology, Medical University of Bialystok, 15-276 Bialystok, Poland.
Cancers
|September 28, 2023
概括
免疫检查点抑制剂 (ICI) 在治疗急性髓性白血病 (AML) 中表现有前途. 在T辅助细胞中较高的PD-1和B7-H3水平与较差的AML患者结果相关,这表明它们作为预测生物标志物的潜力.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 新型药物已经改变了急性髓性白血病 (AML) 的治疗方法.
- 免疫检查点抑制剂 (ICI) 是由于AML免疫系统失调的治疗选择.
- 与固体瘤相比,ICI在血液性恶性瘤中的使用是有限的.
研究的目的:
- 分析AML患者关键免疫检查点蛋白的表达模式.
- 评估免疫检查点表达和治疗结果之间的相关性.
- 为了确定潜在的预测性生物标志物用于AML管理.
主要方法:
- 流细胞测量用于评估PD-1,PD-L1,CTLA-4和B7-H3的表达.
- 分析了72名未经治疗的AML患者的外周血液.
- 患者根据治疗结果和细胞遗传/分子风险进行了分层.
主要成果:
- 非响应者 (NR) 在T辅助细胞 (Th) 中的PD-1频率高于完全缓解 (CR) 患者.
- 在爆发细胞上较低的CTLA-4表达与NR受试者差异化CR.
- Th细胞中PD-1和B7-H3的升高与患者的存活率和预后较差有关.
结论:
- 选择性免疫检查点抑制剂 (ICI) 是AML的显著结果预测剂.
- PD-1和B7-H3的表达水平可以作为AML患者的预后生物标志物.
- 需要多中心研究来验证这些发现的临床应用.
相关概念视频
Tumor Immunotherapy
551
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
551
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cytotoxic T Cells-mediated Immune Response
956
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
956


